A network meta‐analysis (NMA) was conducted to indirectly compare antiangiogenic therapy plus EGFR‐TKIs versus chemotherapy plus EGFR‐TKIs in advanced EGFR‐mutated NSCLC. Here, EGFR is linked to non-small cell lung carcinoma.